Pfizer Ireland Pharmaceuticals Unlimited Company – FDA 483, Jan 26, 2018
An FDA inspection of Pfizer Ireland Pharmaceuticals Inc. in Ringaskiddy, County Cork, Ireland, revealed significant deficiencies in controls for preventing microbial contamination of non-sterile active pharmaceutical ingredients used in sterile drug products. The firm failed to establish adequate controls related to microbial identification during sampling, periodic challenging of equipment preparation effectiveness, and microbiological considerations for clean equipment holding times. These issues pose a risk of contaminating sterile products.
- Inspection date
- January 26, 2018
- Product type
- drugs
ID · f7eafc16-4be8-4075-ac3c-e381c566edef
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.